2m 2m 2m 2m 2m 2m 2m
Henry Schein (HSIC)
NASDAQ
$80.10+$1.43 (+1.81%)
Price as of Jun 23, 2026 5:02 PM EDT- $9.0BMarket Cap
- 9.43%1-Year Change
- Medical DistributionIndustry
Henry Schein (HSIC)
$80.10+$1.43 (+1.81%)
Annual
Quarterly
12/27/2025 | 12/28/2024 | 12/30/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 13.2B +4.03% | 12.7B +2.71% | 12.3B -2.44% | 12.6B +1.98% | |
Cost of Revenue | 9.1B +4.87% | 8.7B +2.11% | 8.5B -3.83% | 8.8B +1.00% | |
Gross Profit | 4.1B +2.22% | 4.0B +4.01% | 3.9B +0.78% | 3.8B +4.32% | |
Sales and Marketing Expense | 3.1B +1.65% | 3.0B +2.64% | 3.0B +6.68% | 2.8B -1.48% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 311.0M +4.71% | 297.0M +19.76% | 248.0M +16.98% | 212.0M +1.18% | |
Total Operating Expenses | 9.1B +4.87% | 8.7B +2.11% | 8.5B -3.83% | 8.8B +1.00% | |
Operating Profit | 653.0M +5.15% | 621.0M +0.98% | 615.0M -17.67% | 747.0M -12.29% | |
Interest Income | 33.0M +37.50% | 24.0M +41.18% | 17.0M 0.00% | 17.0M +163.53% | |
Interest Expense | -150.0M +14.50% | -131.0M +50.57% | -87.0M +97.73% | -44.0M +59.42% | |
Interest Income and Expense and Net | -117.0M +9.35% | -107.0M +52.86% | -70.0M +159.26% | -27.0M +27.67% | |
Total Nonoperating Income and Expense | -3.0M +200.00% | -1.0M -66.67% | -3.0M -400.00% | 1.0M +2,339.02% | |
Income before Taxes | 533.0M +3.90% | 513.0M -5.35% | 542.0M -24.83% | 721.0M -13.19% | |
Income Taxes | 126.0M -1.56% | 128.0M +6.67% | 120.0M -29.41% | 170.0M -13.86% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 398.0M +2.05% | 390.0M -6.25% | 416.0M -22.68% | 538.0M -14.77% | |
Net Income from Continuing Operations Applicable to Common | 398.0M +2.05% | 390.0M -6.25% | 416.0M -22.68% | 538.0M -14.77% | |
Basic EPS and Net Income | 3.29 +7.17% | 3.07 -3.46% | 3.18 -19.49% | 3.95 -12.42% | |
Diluted EPS and Net Income | 3.27 +7.21% | 3.05 -3.48% | 3.16 -19.18% | 3.91 -12.13% | |
Basic Weighted Average Shares | 120.8M -4.71% | 126.8M -2.93% | 130.6M -4.00% | 136.1M -2.87% | |
Diluted Weighted Average Shares | 121.7M -4.74% | 127.8M -3.01% | 131.7M -4.36% | 137.8M -2.83% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 156.0M +27.87% | 122.0M -28.65% | 171.0M +46.15% | 117.0M -0.82% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 156.0M +27.87% | 122.0M -28.65% | 171.0M +46.15% | 117.0M -0.82% | |
Total Current Assets | 4.5B +12.08% | 4.0B -11.25% | 4.5B +12.54% | 4.0B +3.75% | |
Accumulated Depreciation | 759.0M +13.28% | 670.0M -0.30% | 672.0M +17.28% | 573.0M +4.13% | |
Property and Plant and Equipment and Net | 621.0M +16.95% | 531.0M +6.63% | 498.0M +30.03% | 383.0M +4.51% | |
Total Long-Term Assets | 4.0B -29.67% | 5.7B +2.14% | 5.6B +35.37% | 4.1B +1,031.65% | |
Total Assets | 11.2B +9.76% | 10.2B -3.36% | 10.6B +22.84% | 8.6B +1.48% | |
Income Taxes Payable | 325.0M +34.85% | 241.0M +26.18% | 191.0M +13.69% | 168.0M -6.25% | |
Total Short-Term Debt | 797.0M +12.89% | 706.0M +70.53% | 414.0M +279.82% | 109.0M +78.19% | |
Total Current Liabilities | 3.2B +15.16% | 2.8B +4.47% | 2.7B +20.64% | 2.2B -3.58% | |
Total Long-Term Debt | 2.3B +26.23% | 1.8B -5.52% | 1.9B +86.25% | 1.0B +28.18% | |
Total Long-Term Liabilities | 486.0M +25.58% | 387.0M -11.24% | 436.0M +20.78% | 361.0M -4.16% | |
Total Liabilities | 6.4B +19.33% | 5.4B -0.72% | 5.4B +37.70% | 3.9B +3.45% | |
Retained Earnings | 3.3B -12.68% | 3.8B -2.31% | 3.9B +4.95% | 3.7B +2.30% | |
Total Stockholders Equity | 3.2B -4.36% | 3.4B -7.17% | 3.7B +6.07% | 3.4B +0.61% | |
Total Shares Outstanding | 115.8M -6.75% | 124.2M -3.94% | 129.2M -1.93% | 131.8M -3.90% | |
Cash Flow | |||||
Cash from Operating Activities | 712.0M -16.04% | 848.0M +69.60% | 500.0M -16.94% | 602.0M -15.16% | |
Capital Expenditures | 139.0M -6.08% | 148.0M +0.68% | 147.0M +53.13% | 96.0M +21.50% | |
Cash from Investing Activities | -400.0M -6.98% | -430.0M -62.11% | -1.1B +311.23% | -276.0M -59.24% | |
Dividends Paid | -30.0M -44.44% | -54.0M +14.89% | -47.0M +123.81% | -21.0M -17.53% | |
Cash from Financing Activities | -188.0M -63.14% | -510.0M -172.75% | 701.0M +322.54% | -315.0M -5.39% | |
Financials Ratio | |||||
Gross Margin | 31.14% -1.75% | 31.69% +1.27% | 31.29% +3.30% | 30.29% +2.29% | |
Operating Margin | 4.95% +1.08% | 4.90% -1.69% | 4.98% -15.62% | 5.91% -13.99% | |
Return on Assets | 3.71% -1.00% | 3.75% -13.52% | 4.34% -31.11% | 6.30% -18.93% | |
Return on Equity | 11.99% +8.35% | 11.07% -5.55% | 11.72% -25.18% | 15.66% -15.98% | |
Revenue Growth | 4.03% +48.96% | 2.71% +211.15% | -2.44% -222.78% | 1.98% -91.20% | |
Current Ratio | 1.38 -2.68% | 1.42 -15.05% | 1.67 -6.71% | 1.79 +7.60% | |
Cash Ratio | 0.05 +11.03% | 0.04 -31.71% | 0.06 +21.10% | 0.05 +2.94% | |
Debt-to-Equity Ratio | 0.96 +28.11% | 0.75 +16.20% | 0.64 +92.92% | 0.33 +30.90% | |
Debt-to-Assets Ratio | 0.28 +11.60% | 0.25 +11.60% | 0.22 +66.59% | 0.13 +29.74% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow